The tax code holds pitfalls for executives in the form of missed deadlines, deficient agreements and complex regulations governing compensation. This article looks at some of these, including deferred compensation, restricted stock sales and health care compensation after termination.
The Organization for Economic Cooperation and Development says its leading indicator for 33 countries indicates strengthening growth in developed economies and a deepening slowdown in emerging markets. Europe likely will be last to join the recovery of developed economies, the OECD says.
Valeant Pharmaceuticals, Canada's biggest drugmaker, said it will buy eye-care specialist Bausch & Lomb in a deal valued at $8.7 billion. Bausch & Lomb's owner, private equity firm Warburg Pincus, will get $4.5 billion. Bausch & Lomb's existing debt will be paid off with the remaining $4.2 billion.
The FDA has granted approval for Bausch & Lomb's Akreos Advanced Optics Aspheric Lens, a product designed to enhance the vision of cataract patients. The company intends to start marketing the implantable lens by the end of the month.